Mitochondrial function in Huntington's disease: Clues for pathogenesis and prospects for treatment
- 1 February 1997
- journal article
- Published by Wiley in Annals of Neurology
- Vol. 41 (2), 141-142
- https://doi.org/10.1002/ana.410410203
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Energy metabolism defects in Huntington's disease and effects of coenzyme Q10Annals of Neurology, 1997
- A controlled trial of idebenone in Huntington's diseaseMovement Disorders, 1996
- Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenaseHuman Molecular Genetics, 1996
- Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tractNature Genetics, 1996
- Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDHNature Medicine, 1996
- Mitochondrial defect in Huntington's disease caudate nucleusAnnals of Neurology, 1996
- Absence of Disease Phenotype and Intergenerational Stability of the Cag Repeat in Transgenic Mice Expressing the Human Huntington Disease TranscriptHuman Molecular Genetics, 1996
- Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologueNature Genetics, 1995
- Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopyNeurology, 1993
- Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissuesNature Genetics, 1993